In contrast to the loss of bone observed when PTH is continuously applied, intermittent application of exogenous PTH, for example the application of teriparatide in the treatment of osteoporosis, can have an anabolic effect on bone by increasing formation in both cancellous and cortical regions (Figure 6). The gene discussed is PTH; the disease is osteoporosis.